Key points are not available for this paper at this time.
The results suggest that blood biomarkers can be used as research tools to inform the underlying pathophysiological mechanism of concussion and provide additional support for future studies to optimize and validate biomarkers for potential clinical use in SRC.
McCrea et al. (Fri,) studied this question.